Investigators from Montefiore and Einstein to Present Research at American College of Cardiology Meeting
27 Studies to be Presented on Topics Critical to the Cardiology Community
Source Newsroom: Montefiore Medical Center
Newswise — NEW YORK (March 27, 2014) – Investigators from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present findings from 27 studies at the upcoming American College of Cardiology’s 63rd Annual Scientific Session (ACC.14), being held March 29 – 31 in Washington, D.C.
“The robust data from these studies encompass research that could potentially lead to improved mechanisms for treating life-threatening ailments,” said Mario J. Garcia, M.D., chief, Division of Cardiology, Montefiore and Einstein, and co-director, Montefiore Einstein Center for Heart and Vascular Care. “These data highlight our commitment to conducting research that can impact the way we treat cardiovascular disease.”
This year's meeting will feature lectures, debates, symposia, oral abstracts and poster presentations made by nationally and internationally renowned experts on the latest cardiology research and is expected to be the most comprehensive cardiology annual meeting to date. Findings from Montefiore/Einstein researchers will cover a wide range of topics, including acute coronary syndromes, congenital heart disease, non-invasive imaging and pulmonary thrombo-embolic disease.
Among several other Montefiore/Einstein faculty panelists and session moderators, Robert Pass, M.D., director, Pediatric Cardiac Electrophysiology & Pediatric Cardiac Catheterization Laboratory, The Children's Hospital at Montefiore; and associate professor, Pediatrics, Einstein, will discuss the use of implantable defibrillators in children on Monday, March 31.
“Montefiore’s goal is to offer patients the most comprehensive and cutting-edge care available,” said Robert E. Michler, M.D., surgeon-in-chief, Montefiore; professor and chairman, Department of Cardiovascular and Thoracic Surgery, Montefiore and Einstein and co-director, Montefiore Einstein Center for Heart and Vascular Care. “This is made possible by a remarkable team of specialists and researchers at Montefiore and Einstein who use knowledge to drive innovation. We are proud to join the Cardiology community-at-large in sharing our findings and helping to improve patient care and outcomes.”
Selected data to be presented by Montefiore/Einstein researchers include:
• Long-Term Outcomes of Scar-Related VT Ablation for ICM in Sinus Rhythm by Substrate Modification. Embargoed until time of presentation. Presented by Faraj Kargoli, M.D., M.P.H., 10:00 – 10:45 a.m. EDT on Saturday, March 29. (Poster Contributions, Arrhythmias and Clinical EP: VT Session 1107-96, Hall C)
• High Pulmonary Artery Systolic Pressure and Shorter Duration of Cardiomyopathy Predict Improvement in Right Ventricular Function with Continuous Flow LVAD. Embargoed until time of presentation. Presented by Rita A. Jermyn, M.D., 3:45 – 4:00 p.m. EDT on Sunday, March 30. (Poster Contributions, Approaches to Advanced Heart Failure: From VAD, Transplant, Palliative Care to New Percutaneous Therapies Session 1221-183, Hall C)
• Microvascular Obstruction and Intramyocardial Hemorrhage Detected on CMR as Predictors for Mace and Left Ventricle Adverse Remodelling. A Meta-Analysis of Prospective Studies. Embargoed until time of presentation. Presented by Jorge Romero, M.D., 9:45 – 10:30 a.m. EDT on Sunday, March 30. (Poster Contributions, CMR in Ischemic Heart Disease Session 1175-56, Hall C)
• A Retrospective Analysis of Low Flow, Low Gradient Severe Aortic Stenosis with Normal Ejection Fraction: Mortality and Need for Valve Replacement, A Single Center Study. Embargoed until time of presentation. Presented by Faraj Kargoli, M.D., M.P.H., 12:00 – 12:15 p.m. EDT on Sunday, March 30. (Oral Contributions, Valvular Heart Disease Session 928-08, Room 152 B)
• Sleep-Disordered Breathing, Cardiac Biomarkers and Sleepiness in Patients with Acute Myocardial Infarction. Embargoed until time of presentation. Presented by Felipe Albuquerque, M.D., 3:45 – 4:30 p.m. EDT on Sunday, March 30. (Poster Contributions, Acute Coronary Syndromes: Treatment Considerations Session 1226-258, Hall C)
• New-Onset Atrial Fibrillation In Patients Admitted to the Hospital is Associated with Increased Mortality and Risk of Embolic Stroke. Embargoed until time of presentation. Presented by Daniele Massera, M.D., 3:45 – 4:30 p.m. EDT on Saturday, March 29. (Poster Contributions, Arrhythmias and Clinical EP: Advances in Stroke Risk Stratification for Patients with Atrial Fibrillation Session 1143-111, Hall C)
• Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials. Embargoed until time of presentation. Presented by Jorge Romero, M.D., 9:45 – 10:30 a.m. EDT on Sunday, March 30. (Poster Contributions, Coronary and Peripheral Atherosclerosis Session 1176-71, Hall C)
Researchers for each of these studies as well as other Montefiore/Einstein faculty who are attending the meeting are available to speak with media.
About Montefiore Medical Center
As the University Hospital and academic medical center for Albert Einstein College of Medicine, Montefiore is renowned for its clinical excellence, scientific discovery and commitment to its community. Recognized among the top hospitals nationally and regionally by U.S. News & World Report, Montefiore provides compassionate, patient- and family-centered care and educates the healthcare professionals of tomorrow. The Children's Hospital at Montefiore is consistently named in U.S. News' "America's Best Children's Hospitals." With four hospitals, 1,512 beds and more than 84,000 annual admissions, Montefiore is an integrated health system seamlessly linked by advanced technology. State-of-the-art primary and specialty care is provided through a network of more than 150 locations across the region, including the largest school health program in the nation and a home health program. Montefiore's partnership with Einstein advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. The medical center derives its inspiration for excellence from its patients and community, and continues to be on the frontlines of developing innovative approaches to care. For more information please visit www.montefiore.org and www.cham.org. Follow us on Twitter; like us on Facebook; view us on YouTube.
About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2013-2014 academic year, Einstein is home to 734 M.D. students, 236 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 353 postdoctoral research fellows. The College of Medicine has more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates. In 2013, Einstein received more than $155 million in awards from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Through its extensive affiliation network involving Montefiore, Jacobi Medical Center –Einstein’s founding hospital, and five other hospital systems in the Bronx, Manhattan, Long Island and Brooklyn, Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.